CLINICAL_TRIALS
trial_result
· 2025-05-20
Clinical Trial Update: Targeting IL-17A for Treatment-Resistant Depression [Phase 2]
Summary
Phase 2 trial investigating an IL-17A-targeting therapy for treatment-resistant depression has completed and posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Icahn School of Medicine at Mount Sinai | Conditions: Major Depressive Disorder | Phase 2 | Status: COMPLETED | Results posted: 2025-05-20